Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small Cell Lung Cancer: CANOPY-A Trial

被引：0
|
作者：
Garon, Edward B.
Ardizzoni, Andrea
Barlesi, Fabrice
Cho, Byoung Chul
De Marchi, Pedro
Goto, Yasushi
Kowalski, Dariusz
Lu, Shun
Spigel, David R.
Thomas, Michael
Yang, James Chih-Hsin
Turri, Sabine
Zhou, Wen
Kreisl, Teri
Paz-Ares, Luis
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2021年 / 20卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-21-LBA039
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA039
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Canakinumab or Pembrolizumab as Monotherapy or in Combination as Neoadjuvant Therapy in Patients with Surgically Resected Non-Small Cell Lung Cancer: CANOPY-N Trial
    Lee, J.
    Mok, T.
    Garrido, P.
    Kim, E. S.
    Arslan, C.
    Tsuboi, M.
    Dong, T.
    Blin, C.
    Rodrik-Outmezguine, V.
    Mookerjee, B.
    Passos, V.
    Pujol, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [12] Compliance with adjuvant chemotherapy for completely resected non-small cell lung cancer
    Lee, Hyun-Sung
    Kim, Moon Soo
    Lee, Jong Mog
    Kim, Heung Tae
    Zo, Jae Ill
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S480 - S480
  • [13] Adjuvant therapy in completely resected non-small-cell lung cancer
    Giorgio V. Scagliotti
    Silvia Novello
    Current Oncology Reports, 2003, 5 (4) : 318 - 325
  • [14] Referral patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer
    Kassam, Farrah
    Shepherd, Frances A.
    Johnston, Michael
    Visbal, Antonio
    Feld, Ronald
    Darling, Gail
    Keshavjee, Shaf
    Pierre, Andrew
    Waddell, Thomas
    Leighl, Natasha B.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (01) : 39 - 43
  • [15] Canakinumab or pembrolizumab as monotherapy or in combination as neoadjuvant therapy in patients with surgically resected non-small cell lung cancer: CANOPY-N trial.
    Lee, Jay M.
    Mok, Tony
    Garrido, Pilar
    Kim, Edward S.
    Arslan, Cagatay
    Tsuboi, Masahiro
    Dong, Tuochuan
    Blin, Cecile
    Rodrik-Outmezguine, Vanessa
    Mookerjee, Bijoyesh
    Passos, Vanessa
    Pujol, Jean-Louis
    CANCER RESEARCH, 2021, 81 (13)
  • [16] Canakinumab or Pembrolizumab as Monotherapy or in Combination as Neoadjuvant Therapy in Patients with Surgically Resected Non-Small Cell Lung Cancer (NSCLC): CANOPY-N Trial
    Lee, J.
    Garrido, P.
    Kim, E.
    Arslan, C.
    Pujol, J. L.
    Tsuboi, M.
    Dong, T.
    Blin, C.
    Rodrik-Outmezguine, V.
    Mookerjee, B.
    Passos, V.
    Mok, T.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S25 - S26
  • [17] Postoperative adjuvant therapy for completely resected early-stage non-small cell lung cancer
    Harubumi Kato
    Masahiro Tsuboi
    Yasufumi Kato
    Norihiko Ikeda
    Tetsuya Okunaka
    Chikuma Hamada
    International Journal of Clinical Oncology, 2005, 10 (3) : 157 - 164
  • [18] Adjuvant chemotherapy for completely resected non-small cell lung cancer: A systematic review
    Alam, Naveed
    Darling, Gail
    Evans, William K.
    Mackay, Jean A.
    Shepherd, Frances A.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 58 (02) : 146 - 155
  • [19] Is there a role for adjuvant therapy for resected non-small cell lung cancer?
    Jett, JR
    THORAX, 1999, 54 : S37 - S41
  • [20] Phase II Trial of Adjuvant Atezolizumab Therapy in Elderly Patients with Completely Resected Stage II/III Non-Small Cell Lung Cancer: RELIANCE Trial
    Matsubara, Taichi
    Yamaguchi, Masafumi
    Shimokawa, Mototsugu
    Okamoto, Isamu
    CLINICAL LUNG CANCER, 2024, 25 (03) : 280 - 283
12345